NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
* Return to Stem Cells Alert Section

Data from Massachusetts General Hospital provide new insights into stem cell research



December 8th, 2008

   2008 DEC 8 -- Fresh data on stem cell research are presented in the report 'Human embryonic stem cells: emerging technologies and practical applications.' "Human embryonic stem cells possess the unique ability to differentiate into any adult cell type. Recent advances in the understanding of stem cell biology make new applications possible for stem cell based technology," scientists in the United States report.

   "Of note, it is now possible to reprogram terminally differentiated human somatic cells into pluripotent cells that are functionally equivalent to embryonic stem cells. These induced pluripotent cells may become the substrate for future disease models and cell-based therapies. In addition, novel techniques for genetic manipulation have increased the ease with which genes can be modified into stem cells," wrote L.E. Fenno and colleagues, Massachusetts General Hospital.

   The researchers concluded: "In this review, we describe these novel technologies as well as developments in the understanding of basic biology of stem cell pluripotency and differentiation."

   Fenno and colleagues published their study in Current Opinion In Genetics & Development (Human embryonic stem cells: emerging technologies and practical applications. Current Opinion In Genetics & Development, 2008;18(4):324-9).

   For additional information, contact L.E. Fenno, Stowers Medical Institute, Harvard Stem Cell Institute, Center for Regenerative Medicine, Cardiovascular Research Center, Massachusetts General Hospital, 185 Cambridge Street, CPZN-4234, Boston, MA 02114, United States.

   The publisher's contact information for the journal Current Opinion In Genetics & Development is: Current Biology Ltd., 84 Theobalds Rd., London WC1X 8RR, England.

   Keywords: United States, Boston, Cell Biology, Embryonic Stem Cell Research.

   This article was prepared by Stem Cell Week editors from staff and other reports. Copyright 2008, Stem Cell Week via NewsRx.com.

Return to Stem Cells Alert Section

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login